《国家三级公立医院绩效考核操作手册(2022版)》药事管理指标解读及思考  

Interpretation and thinking of indicators of pharmaceutical administration in National Tertiary Public Hospitals Performance Evaluation Operational Manual(2022 edition)

作　　者：徐思露 吴楠[1] 蔡宁[1] 赵敏[1] 潘杰[2] 魏继福 XU Silu;WU Nan;CAI Ning;ZHAO Min;PAN Jie;WEI Jifu(Dept.of Pharmacy,Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/the Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210009,China;Dept.of Pharmacy,the Second Affiliated Hospital of Soochow University,Jiangsu Suzhou 215004,China)

机构地区：[1]江苏省肿瘤医院/江苏省肿瘤防治研究所/南京医科大学附属肿瘤医院药学部,南京210009 [2]苏州大学附属第二医院药剂科,江苏苏州215004

出　　处：《中国药房》2022年第13期1541-1547,共7页China Pharmacy

基　　金：江苏省医学创新团队培养资助项目(No.CXT-DA2017049);江苏省肿瘤医院科技发展基金资助项目(No.ZG202102)。

摘　　要：目的解读《国家三级公立医院绩效考核操作手册(2022版)》(以下简称《手册(2022版)》)中关于药事管理的指标修订,为医院推动新版绩效考核方案中药事管理部分的落地与执行提供参考。方法简述《手册(2022版)》药事管理指标内容及修订明细,并对修订内容进行解读,提出相关建议。结果与结论《手册(2022版)》延续《手册(2020版)》的绩效考核范围、指标架构和顺序,聚焦合理用药与药品费用控制。《手册(2022版)》更加强调加强基本药物、集中采购中选药品的配备使用,以及进一步减轻患者医药费用负担等内容。建议三级公立医院科学设置临床科室基本药物、集中采购中选药品、辅助用药、抗菌药物使用指标,完善相关激励机制和绩效考核制度;加强基本药物、集中采购政策解读和合理用药宣传培训;优化院内用药目录和药品处方集;通过制定用药规范,加大处方审核、合理用药点评和考核力度;运用信息化手段建立和完善药品使用监测评价和预警制度以规范临床用药行为;在保证合理的基础上加强基本药物、集中采购中选药品的使用;通过合理用药管控以控制药品费用不合理增长,使次均药品费用增幅逐步降低。OBJECTIVE To interpret the revision of the indicators of pharmaceutical administration in National Tertiary Public Hospitals Performance Evaluation Operational Manual(2022 edition)[hereinafter referred to as the Mannual(2022 edition)],and to provide reference for the implementation of a new round of performance appraisal in tertiary public hospitals.METHODS The contents and revision details of the indicators of pharmaceutical administration in the Mannual(2022 edition)were described briefly,and the revised contents were interpreted and relevant suggestions were put forward.RESULTS&CONCLUSIONS The Manual(2022 edition)continued the scope of performance evaluation,indicators’structure and sequence in the Manual(2020 edition),which focused on rational drug use and drug cost control.The Manual(2022 edition)placed more emphasis on strengthening the provision and use of essential medicines and selected drugs in the centralized drug procurement,and further reducing the burden of medical costs in patients.It is suggested that tertiary public hospitals scientifically set indicators for the use of essential medicines,selected drugs in the centralized drug procurement,auxiliary drugs and antibacterial drugs in clinical departments,and improve relevant incentive mechanisms and performance assessment systems;strengthen the interpretation of policies about essential medicines and drug centralized procurement,as well as the training of rational drug use;optimize in-hospital drug catalog and formulary;formulate medication standards,strengthen prescription review,rational medication review and assessment;establish and improve the drug use monitoring and evaluation and early warning system so as to standardize clinical drug use behavior by information technology;strengthen the use of essential drugs and centrally purchase selected drugs on the basis of ensuring rationality;control the unreasonable increase in drug costs through rational drug use control to gradually reduce the increase in average drug costs.

关 键 词：三级公立医院 绩效考核 药事管理指标 基本药物 药品集中采购 

分 类 号：R951[医药卫生—药学]